ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668833 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668833; 2) Community: the network communities that were significantly associated with the response to NSC 668833; 3) Molecule: the relationships between components within communities and NSC 668833; 4) MDR: the compounds that were significantly associated with the NSC 668833.

NSC Compound Enrichment Correlation
NSC 737147 2-(4-Chloroanilino)-N'-[(4-acetylaminophenyl)sulphonyl]nicotino hydrazide 0.0178844438004195 -0.019014057
NSC 748146 5-bromo-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0178844438004195 0.022100967
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.0178844438004195 0.19399664
NSC 748870 Null 0.0178844438004195 0.10004049
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.0178844438004195 0.092529605
NSC 758706 Simvastatin (USAN) 0.0178844438004195 0.29081987
NSC 759274 ARSENIC TRIOXIDE 0.0178844438004195 0.089955712
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0178844438004195 0.070743216
NSC 87500 Solacongestidine 0.0178844438004195 -0.056721378
NSC 676776 Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-D-xylopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylopyranosyl)]- 0.0179905510964914 -0.23569207
Total:59  Current:19    [First] [Prev] [Next] [Last]